An interventional study of Control exercises and gaze stabilization exercises in Vestibular Neuronitis, Vestibular Neuronitis, Bilateral and Vestibular Schwannoma, sponsored by Emory University. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-08-07.
Sponsored by Emory University · Not applicable, Interventional, and Treatment
The purpose of this study is to determine whether exercises relieve the symptoms of dizziness and imbalance in people with vestibular deficits and improves the ability to see clearly during head movements. We hypothesize that the performance of specific adaptation and substitution exercises will result in an improvement in visual acuity during head movements while those patients performing placebo exercises will show no improvement.
Decrements in visual acuity during head movement in patients with vestibular hypofunction are potentially serious problems. This deficit could contribute to decreased activity level, avoidance of driving with resultant diminished independence and, ultimately, limited social interactions and increased isolation. Oscillopsia occurs because of inadequate vestibulo-ocular reflex (VOR) gain and suggests that compensation for the vestibular loss has not occurred. The purpose of this study was to examine the effect of an exercise intervention on visual acuity during head movement in patients with unilateral and bilateral vestibular hypofunction. We hypothesized that 1) patients performing vestibular exercises would have improved visual acuity during head movement compared to patients performing placebo exercises; 2) there would be no correlation between dynamic visual acuity (DVA) and the patients' subjective complaints of oscillopsia; and 3) improvement in DVA would be reflected by changes in residual vestibular function as indicated by an increase in VOR gain.
Patients are assigned randomly to either the vestibular exercise or placebo exercise group. The randomization schedule is generated using a computer program for 2-sample randomization. The sequence was not concealed from the investigator who obtained consent from the subjects and supervised the exercises (SJH). The group assignment (vestibular exercise or placebo exercise) was concealed from the participants and from the investigator who performed the outcome measures.
The vestibular exercise group practiced exercises that consisted of adaptation exercises and eye-head exercises to targets (Table 1), which were designed to improve gaze stability 16. They also performed gait and balance exercises. The placebo exercise group performed exercises designed to be 'vestibular-neutral'.
34 studies on the registry are indexed under Vestibular Neuronitis; 4 are open to participants now.
This study's enrollment of 23 is below the median of 50 across 27 interventional studies indexed under Vestibular Neuronitis.
Browse Vestibular Neuronitis studies →Emory University is the lead sponsor of 1,405 studies on the registry; 225 are open to participants now.
Of its 237 completed or terminated interventional studies of FDA-regulated products, 178 (75%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Experimental group performed vestibular adaptation and substitution exercises
Other: gaze stabilization exercises
Saccadic eye movements against a Ganzfeld to prevent retinal slip error signal; no head movements
Other: Control exercises
saccadic eye movements against a plain background; no head movements
adaptation and substitutin exercises encorporating retinal lsip and head movements
Change in Visual Acuity During Head Movement From Baseline to Discharge
visual acuity is measured using a computerized system first with the head stationary and then with the head moving in yaw plane. Head velocity is measured using a rate sensor and optotype is displayed only when head velocity is between 120 and 180 degrees per second. The change in visual acuity was calculated from subtracting the discharge measurement from the baseline measurement (pre-intervention).
Time frame: pre-intervention and at discharge
Subjective Complaints: (All Pre- and Post-intervention):
questionnaire
Time frame: pre-intervention, 2 weeks, 4 weeks and at discharge
Disability Scale
questionnaire
Time frame: pre-intervention, 2 weeks, 4 weeks and at discharge
Activities Specific Balance Confidence Scale
questionnaire
Time frame: pre-intervention, 2 weeks, 4 weeks and at discharge
Symptoms Intensity for Dizziness, Oscillopsia, Disequilibrium
visual analoque scales
Time frame: pre-intervention, 2 weeks, 4 weeks and at discharge
Balance and Gait
gait speed
Time frame: pre-intervention, 2 weeks, 4 weeks and at discharge
Fall Risk (Dynamic Gait Index)
performance test
Time frame: pre-intervention, 2 weeks, 4 weeks and at discharge
Eye Movements: Scleral Search Coil
eye movements are measured by having the participant sit within an electromagnetic field while wearing a scleral coil (like a contact lens but only in contact with the sclea, not the cornea); te coil moves with eye movement and distorts the electrimagnetic field
Time frame: pre- and post-treatment
| Milestone | Exercises for Gaze Stabilization | Control Exercises |
|---|---|---|
| Started | 13 | 10 |
| Completed | 13 | 8 |
| Not completed | 0 | 2 |
| Withdrew: Ten participants were entered into the c | 0 | 2 |
visual acuity is measured using a computerized system first with the head stationary and then with the head moving in yaw plane. Head velocity is measured using a rate sensor and optotype is displayed only when head velocity is between 120 and 180 degrees per second. The change in visual acuity was calculated from subtracting the discharge measurement from the baseline measurement (pre-intervention).
| LogMAR | Exercises for Gaze Stabilization | Control Exercises |
|---|---|---|
| Change in Visual Acuity During Head Movement From Baseline to Discharge | 0.198 ± 0.101 | .296 ± .122 |
questionnaire
Results for this outcome have not been posted.
questionnaire
Results for this outcome have not been posted.
questionnaire
Results for this outcome have not been posted.
visual analoque scales
Results for this outcome have not been posted.
gait speed
Results for this outcome have not been posted.
performance test
Results for this outcome have not been posted.
eye movements are measured by having the participant sit within an electromagnetic field while wearing a scleral coil (like a contact lens but only in contact with the sclea, not the cornea); te coil moves with eye movement and distorts the electrimagnetic field
Results for this outcome have not been posted.
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Exercises for Gaze Stabilization | — | 0/13 (0%) | 0/13 (0%) |
| Control Exercises | — | 0/8 (0%) | 0/8 (0%) |
| Event | Exercises for Gaze Stabilization | Control Exercises |
|---|---|---|
| fallsNervous system disorders | 0/13 | 0/8 |
| Age, Continuous(years) | Exercises for Gaze Stabilization | Control Exercises | Total |
|---|---|---|---|
| Mean | 65.2 ± 16.5 | 64.9 ± 16.2 | 65.1 ± 16.3 |
| Age, Categorical(Participants) | Exercises for Gaze Stabilization | Control Exercises | Total |
|---|---|---|---|
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 6 | 5 | 11 |
| >=65 years | 7 | 5 | 12 |
| Sex: Female, Male(Participants) | Exercises for Gaze Stabilization | Control Exercises | Total |
|---|---|---|---|
| Female | 9 | 6 | 15 |
| Male | 4 | 4 | 8 |
| Region of Enrollment(participants) | Exercises for Gaze Stabilization | Control Exercises | Total |
|---|---|---|---|
| United States | 13 | 10 | 23 |
| Visual acuity during head movements(LogMAR) | Exercises for Gaze Stabilization | Control Exercises | Total |
|---|---|---|---|
| Mean | .372 ± .155 | .323 ± .117 | .348 ± .136 |
This study is completed, as verified in Jul 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.